MedPath

Sex Differences in the Risk of Cardiovascular Diseases Associated With Diabetes

Conditions
Diabetes Mellitus
Registration Number
NCT02542774
Lead Sponsor
University College, London
Brief Summary

To evaluate the risk of cardiovascular events associated with medication use for controlling blood glucose, blood pressure and cholesterol levels in men and women with diabetes treated in primary care

Detailed Description

The management and treatment of adult diabetes is far from optimal. The most recent report from the National Diabetes Audit showed that only one in three people with diabetes are achieving recommended standards for controlling blood glucose, blood pressure and cholesterol levels; and only three in five received basic care processes to reduce their risk of diabetes-related complications such as blindness, amputation and kidney disease. Women did 15% worse than men, which may explain some of the reported higher excess risk of coronary heart disease and stroke, consequent to diabetes in women than men. More efficient and equitable care in people with diabetes could lead to substantial cost savings, and would improve the lives of women and men currently living with diabetes.

The objective of this research isto evaluate the risk of cardiovascular events associated with medication use for controlling blood glucose, blood pressure and cholesterol levels in men and women with diabetes treated in primary care.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80000
Inclusion Criteria
  • Patients with diabetes at or before study entry, and participants who develop new-onset diabetes during follow-up.
  • Age ≥ 18 years
  • Data collected in the period 1997-2010
  • Minimum time since registration of 1 year
  • Minimum of 1 year of up to standard data (CPRD quality standard)
Exclusion Criteria

• None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
First occurrence of cardiovascular disease10 years

First recorded diagnosis of cardiovascular disease during follow-up: stable angina, unstable angina, myocardial infarction, unheralded coronary death, heart failure, transient ischaemic attack, ischaemic stroke, subarachnoid haemorrhage, intracerebral haemorrhage, peripheral arterial disease, abdominal aortic aneurysm, ventricular arrhythmia, cardiac arrest, or sudden cardiac death

Secondary Outcome Measures
NameTimeMethod
Cardiovascular mortality10 years

Composite endpoint of cardiovascular mortality

All cause mortality10 years

Composite endpoint of all cause mortality

Trial Locations

Locations (1)

The George Institute for Global Health, Nuffield Department for Population Health, University of Oxford

🇬🇧

Oxford, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath